Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |